Imatinib in small cell lung cancer
Data up to Jan 2025
Total Citations Per Year
Abstract
References (21)
Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia
2001 • 5,189 citations
Cancer Statistics, 2003
2003 • 3,302 citations
A gene hypermethylation profile of human cancer.
2001 • 2,043 citations
Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand.
1987 • 1,627 citations
Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study
2002 • 1,195 citations
Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 study
2002 • 1,069 citations
Lessons learned from the development of an Abl tyrosine kinase inhibitor for chronic myelogenous leukemia
2000 • 897 citations
STI571 inactivation of the gastrointestinal stromal tumor c-KIT oncoprotein: biological and clinical implications
2001 • 698 citations
KIT Extracellular and Kinase Domain Mutations in Gastrointestinal Stromal Tumors
2000 • 648 citations
Inhibition of KIT Tyrosine Kinase Activity: A Novel Molecular Approach to the Treatment of KIT-Positive Malignancies
2002 • 582 citations
Lack of PTEN expression in non-small cell lung cancer could be related to promoter methylation.
2002 • 396 citations
Autocrine growth of small cell lung cancer mediated by coexpression of c-kit and stem cell factor.
1996 • 275 citations
The selective tyrosine kinase inhibitor STI571 inhibits small cell lung cancer growth.
2000 • 271 citations
Growth inhibition and modulation of kinase pathways of small cell lung cancer cell lines by the novel tyrosine kinase inhibitor STI 571
2000 • 238 citations
Update of phase I study of imatinib (STI571) in advanced soft tissue sarcomas and gastrointestinal stromal tumors: a report of the EORTC Soft Tissue and Bone Sarcoma Group
2002 • 231 citations
Phase II study of topotecan in patients with extensive-stage small-cell carcinoma of the lung: an Eastern Cooperative Oncology Group Trial.
1996 • 206 citations
Characterization of c-kit expression in small cell lung cancer: prognostic and therapeutic implications.
2003 • 146 citations
Platelet-derived growth factor receptors: A therapeutic target in solid tumors
2001 • 145 citations
The biology of lung cancer.
1993 • 143 citations
Small Cell Lung Cancer
1997 • 135 citations
Justification for Evaluating New Anticancer Drugs in Selected Untreated Patients With Extensive-Stage Small-Cell Lung Cancer: An Eastern Cooperative Oncology Group Randomized Study
1992 • 42 citations
Cited By (0)
No citing papers found in database